VTRS

VIATRIS INC

VTRS·92556V106·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

VTRS (VIATRIS INC) is held by 263 institutional investors as of Q2 2026. Largest holders: FMR LLC ($1.5B), BlackRock, Inc. ($1.4B), VANGUARD CAPITAL MANAGEMENT LLC ($1.2B). Net institutional sentiment: Mixed. In Q2 2026, 2 members of Congress and 144 funds bought VTRS.

263
Holders
(25 Elite)
$13.2B
Total Value
54% (268)
Consensus
144 buying - 124 selling
13F: Insider & Congress: Updated regularly
VTRS

Smart Money Verdict

View all
Loading verdict
Held by 263 funds
25 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Aug 18, 2026 · Activists Aug 12, 2026 · Congress Dec 15, 2025

InsiderEAEnrietti AndrewTax 11K shAug 15, 2026
InsiderEAEnrietti AndrewTax 435 shAug 15, 2026
InsiderEAEnrietti AndrewExercise 999 shAug 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
96.7M(+482.7%)$1.5B0.1%+9.02%
51
Increased
86M(+2.0%)$1.4B0.0%+40.92%
32
Increased
76M(+1.8%)$1.2B0.0%+22.36%
32
Decreased
75.2M(-3.8%)$1.2B5.1%+48.78%
0
Increased
54.3M(+0.7%)$862M0.0%+22.60%
32
Increased
53.1M(+1.6%)$842.7M0.0%+66.48%
32
Increased
32.8M(+3.0%)$520.1M0.0%+20.77%
32
Decreased
30M(-21.8%)$476M0.1%+80.76%
0
Decreased
20.8M(-5.5%)$329.8M0.0%+56.00%
0
Decreased
18.8M(-6.0%)$298.8M0.1%+80.54%
0
Decreased
15.1M(-6.0%)$240.2M0.0%+70.03%
0
Increased
14.3M(+1.1%)$226.9M0.0%+34.45%
31
Decreased
13.6M(-0.8%)$215.4M0.0%+26.44%
0
Decreased
13.6M(-1.1%)$215.4M0.0%+33.82%
0
Decreased
10M(-4.0%)$159.4M0.0%+16.51%
0
Increased
9.9M(+8.7%)$156.9M2.9%+47.56%
58
Decreased
8.4M(-2.0%)$132.9M0.1%+88.74%
0
Increased
7.9M(+21.2%)$125.3M0.0%+34.38%
36
Increased
7.3M(+27.8%)$119.7M0.0%+40.24%
37
Increased
7.4M(+1.3%)$116.8M0.0%+54.25%
30

Showing 1-20 of 285

1 / 15
VTRSVTRSVIATRIS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used